PMID- 34717872
OWN - NLM
STAT- MEDLINE
DCOM- 20220127
LR  - 20220127
IS  - 1558-1942 (Electronic)
IS  - 0889-8553 (Linking)
VI  - 50
IP  - 4
DP  - 2021 Dec
TI  - Endoscopic and Surgical Management of Gastroesophageal Reflux Disease.
PG  - 809-823
LID - S0889-8553(21)00704-4 [pii]
LID - 10.1016/j.gtc.2021.07.005 [doi]
AB  - Approximately, 10% to 15% of patients in the United States experience 
      gastroesophageal reflux symptoms on a weekly basis, negatively affecting the 
      quality of life and increasing the risk of reflux-related complications. For 
      patients with symptoms recalcitrant to proton pump inhibitor (PPI) therapy or 
      those who cannot take PPIs, surgical fundoplication is the gold standard. The 
      preoperative workup is complex but vital for operative planning and ensuring good 
      postoperative outcomes. Most patients are highly satisfied after fundoplication, 
      though transient dysphagia, gas bloating, and resumption of PPI use are common 
      postoperatively. Multiple newer technologies offer safe alternatives to 
      fundoplication with similar outcomes.
CI  - Copyright (c) 2021 Elsevier Inc. All rights reserved.
FAU - Zimmermann, Christopher J
AU  - Zimmermann CJ
AD  - Department of Surgery, University of Wisconsin- Madison, Clinical Science Center, 
      600 Highland Avenue, Madison, WI 53792-7375, USA.
FAU - Lidor, Anne
AU  - Lidor A
AD  - Department of Surgery, University of Wisconsin- Madison, Clinical Science Center, 
      600 Highland Avenue, Madison, WI 53792-7375, USA. Electronic address: 
      lidor@surgery.wisc.edu.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20211007
PL  - United States
TA  - Gastroenterol Clin North Am
JT  - Gastroenterology clinics of North America
JID - 8706257
SB  - IM
MH  - Fundoplication
MH  - *Gastroesophageal Reflux/drug therapy/surgery
MH  - Humans
MH  - *Laparoscopy
MH  - Quality of Life
MH  - Treatment Outcome
OTO - NOTNLM
OT  - ARMS
OT  - Fundoplication
OT  - GERD
OT  - LINX
OT  - Nissen
OT  - Stretta
OT  - TIF
COIS- Disclosure The authors have nothing to disclose.
EDAT- 2021/11/01 06:00
MHDA- 2022/01/28 06:00
CRDT- 2021/10/31 20:44
PHST- 2021/10/31 20:44 [entrez]
PHST- 2021/11/01 06:00 [pubmed]
PHST- 2022/01/28 06:00 [medline]
AID - S0889-8553(21)00704-4 [pii]
AID - 10.1016/j.gtc.2021.07.005 [doi]
PST - ppublish
SO  - Gastroenterol Clin North Am. 2021 Dec;50(4):809-823. doi: 
      10.1016/j.gtc.2021.07.005. Epub 2021 Oct 7.